231 related articles for article (PubMed ID: 10779554)
1. Preservation of myocardial beta-adrenergic receptor signaling delays the development of heart failure after myocardial infarction.
White DC; Hata JA; Shah AS; Glower DD; Lefkowitz RJ; Koch WJ
Proc Natl Acad Sci U S A; 2000 May; 97(10):5428-33. PubMed ID: 10779554
[TBL] [Abstract][Full Text] [Related]
2. In vivo inhibition of elevated myocardial beta-adrenergic receptor kinase activity in hybrid transgenic mice restores normal beta-adrenergic signaling and function.
Akhter SA; Eckhart AD; Rockman HA; Shotwell K; Lefkowitz RJ; Koch WJ
Circulation; 1999 Aug; 100(6):648-53. PubMed ID: 10441103
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of betaARK1 restores impaired biochemical beta-adrenergic receptor responsiveness but does not rescue CREB(A133) induced cardiomyopathy.
Eckhart AD; Fentzke RC; Lepore J; Lang R; Lin H; Lefkowitz RJ; Koch WJ; Leiden JM
J Mol Cell Cardiol; 2002 Jun; 34(6):669-77. PubMed ID: 12054854
[TBL] [Abstract][Full Text] [Related]
4. Ventricular dysfunction after cardioplegic arrest is improved after myocardial gene transfer of a beta-adrenergic receptor kinase inhibitor.
Tevaearai HT; Eckhart AD; Shotwell KF; Wilson K; Koch WJ
Circulation; 2001 Oct; 104(17):2069-74. PubMed ID: 11673348
[TBL] [Abstract][Full Text] [Related]
5. The myocardial beta-adrenergic system in spontaneously hypertensive heart failure (SHHF) rats.
Anderson KM; Eckhart AD; Willette RN; Koch WJ
Hypertension; 1999 Jan; 33(1 Pt 2):402-7. PubMed ID: 9931137
[TBL] [Abstract][Full Text] [Related]
6. Effects of two Gbetagamma-binding proteins--N-terminally truncated phosducin and beta-adrenergic receptor kinase C terminus (betaARKct)--in heart failure.
Li Z; Laugwitz KL; Pinkernell K; Pragst I; Baumgartner C; Hoffmann E; Rosport K; Münch G; Moretti A; Humrich J; Lohse MJ; Ungerer M
Gene Ther; 2003 Aug; 10(16):1354-61. PubMed ID: 12883532
[TBL] [Abstract][Full Text] [Related]
7. Expression of a beta-adrenergic receptor kinase 1 inhibitor prevents the development of myocardial failure in gene-targeted mice.
Rockman HA; Chien KR; Choi DJ; Iaccarino G; Hunter JJ; Ross J; Lefkowitz RJ; Koch WJ
Proc Natl Acad Sci U S A; 1998 Jun; 95(12):7000-5. PubMed ID: 9618528
[TBL] [Abstract][Full Text] [Related]
8. Level of beta-adrenergic receptor kinase 1 inhibition determines degree of cardiac dysfunction after chronic pressure overload-induced heart failure.
Tachibana H; Naga Prasad SV; Lefkowitz RJ; Koch WJ; Rockman HA
Circulation; 2005 Feb; 111(5):591-7. PubMed ID: 15668342
[TBL] [Abstract][Full Text] [Related]
9. Acute ischemic cardiac dysfunction is attenuated via gene transfer of a peptide inhibitor of the beta-adrenergic receptor kinase (betaARK1).
Tevaearai HT; Walton GB; Keys JR; Koch WJ; Eckhart AD
J Gene Med; 2005 Sep; 7(9):1172-7. PubMed ID: 15880449
[TBL] [Abstract][Full Text] [Related]
10. Donor heart contractile dysfunction following prolonged ex vivo preservation can be prevented by gene-mediated beta-adrenergic signaling modulation.
Tevaearai HT; Walton GB; Eckhart AD; Keys JR; Koch WJ
Eur J Cardiothorac Surg; 2002 Nov; 22(5):733-7. PubMed ID: 12414039
[TBL] [Abstract][Full Text] [Related]
11. betaARK1 inhibition improves survival in a mouse model of heart failure induced by myocardial infarction.
Suzuki Y; Nakano K; Sugiyama M; Imagawa J
J Cardiovasc Pharmacol; 2004 Sep; 44(3):329-34. PubMed ID: 15475830
[TBL] [Abstract][Full Text] [Related]
12. Targeted beta-adrenergic receptor kinase (betaARK1) inhibition by gene transfer in failing human hearts.
Williams ML; Hata JA; Schroder J; Rampersaud E; Petrofski J; Jakoi A; Milano CA; Koch WJ
Circulation; 2004 Apr; 109(13):1590-3. PubMed ID: 15051637
[TBL] [Abstract][Full Text] [Related]
13. In vivo ventricular gene delivery of a beta-adrenergic receptor kinase inhibitor to the failing heart reverses cardiac dysfunction.
Shah AS; White DC; Emani S; Kypson AP; Lilly RE; Wilson K; Glower DD; Lefkowitz RJ; Koch WJ
Circulation; 2001 Mar; 103(9):1311-6. PubMed ID: 11238278
[TBL] [Abstract][Full Text] [Related]
14. Reciprocal in vivo regulation of myocardial G protein-coupled receptor kinase expression by beta-adrenergic receptor stimulation and blockade.
Iaccarino G; Tomhave ED; Lefkowitz RJ; Koch WJ
Circulation; 1998 Oct; 98(17):1783-9. PubMed ID: 9788834
[TBL] [Abstract][Full Text] [Related]
15. Targeted inhibition of beta-adrenergic receptor kinase-1-associated phosphoinositide-3 kinase activity preserves beta-adrenergic receptor signaling and prolongs survival in heart failure induced by calsequestrin overexpression.
Perrino C; Naga Prasad SV; Patel M; Wolf MJ; Rockman HA
J Am Coll Cardiol; 2005 Jun; 45(11):1862-70. PubMed ID: 15936620
[TBL] [Abstract][Full Text] [Related]
16. Restoration of beta-adrenergic signaling in failing cardiac ventricular myocytes via adenoviral-mediated gene transfer.
Akhter SA; Skaer CA; Kypson AP; McDonald PH; Peppel KC; Glower DD; Lefkowitz RJ; Koch WJ
Proc Natl Acad Sci U S A; 1997 Oct; 94(22):12100-5. PubMed ID: 9342369
[TBL] [Abstract][Full Text] [Related]
17. Restoration of beta-adrenergic receptor signaling and contractile function in heart failure by disruption of the betaARK1/phosphoinositide 3-kinase complex.
Perrino C; Naga Prasad SV; Schroder JN; Hata JA; Milano C; Rockman HA
Circulation; 2005 May; 111(20):2579-87. PubMed ID: 15897344
[TBL] [Abstract][Full Text] [Related]
18. Expression of a beta-adrenergic receptor kinase inhibitor reverses dysfunction in failing cardiomyocytes.
Eckhart AD; Koch WJ
Mol Ther; 2002 Jan; 5(1):74-9. PubMed ID: 11786048
[TBL] [Abstract][Full Text] [Related]
19. Cardiac betaARK1 upregulation induced by chronic salt deprivation in rats.
Iaccarino G; Barbato E; Cipolleta E; Esposito A; Fiorillo A; Koch WJ; Trimarco B
Hypertension; 2001 Aug; 38(2):255-60. PubMed ID: 11509486
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of Na+/H+-exchanger with sabiporide attenuates the downregulation and uncoupling of the myocardial beta-adrenoceptor system in failing rabbit hearts.
Leineweber K; Aker S; Beilfuss A; Rekasi H; Konietzka I; Martin C; Heusch G; Schulz R
Br J Pharmacol; 2006 May; 148(2):137-46. PubMed ID: 16520740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
